Clinical Trial Update: A Study of Trabectedin in Patients With Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of trabectedin in advanced ovarian cancer (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Trabectedin (Yondelis) (trabectedin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Ovarian Neoplasms, Endocrine Gland Neoplasms | Phase 2 | Status: COMPLETED